ChartRow logo
Share this page
HAE
$118.28-2.48%
as of close, Oct 16, 2026
☾ AH $118.28 -2.48%
Haemonetics CorporationStock · HealthcareRussell 2000 0.1%Russell 3000 0.005%US Stock Market 0.005%
PeersMRNALLYMDTUNHJNJTMO

HAE financial statements

The full income statement, balance sheet, and cash-flow statement for Haemonetics Corporation (HAE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 51.2M2024-09 50.2M2024-12 50.2M2025-03 48.0M2025-06 48.2M2025-09 46.8M2025-12 46.5M2026-03 45.4M2026-06 45.5M-11.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022FY2021
Income Statementas ofMar 28 ’26as ofMar 29 ’25as ofMar 30 ’24as ofApr 1 ’23as ofApr 2 ’22as ofApr 3 ’21
Revenue1.33B-2.0%1.36B+4.0%1.31B+12.0%1.17B+17.7%993M+14.1%870M-11.9%
788M+5.2%749M+8.3%692M+12.4%615M+21.7%506M+27.1%398M-17.9%
Cost of revenue546M-10.7%612M-0.9%618M+11.6%554M+13.5%488M+3.2%473M-6.2%
631M+19.7%527M+0.1%527M+14.7%459M+8.1%425M+37.9%308M-19.2%
Research & development59.8M-4.7%62.7M+15.2%54.4M+8.6%50.1M+7.1%46.8M+42.4%32.9M+6.4%
Selling, general & administrative442M+1.3%437M+1.6%430M+14.1%377M+10.7%340M+23.6%275M-2.4%
Restructuring3.11M-77.6%13.9M-1.2%14.1M+2044.4%657K-84.5%4.23M+192.9%1.44M-59.8%
Amortization of intangibles50.5M-9.2%55.6M+34.3%41.4M-1.7%42.1M-25.6%56.6M+37.4%41.2M+20.5%
Provision for credit losses615K-15.2%725K-13.7%840K-68.0%2.62M+630.6%359K-63.8%991K+371.5%
Operating income157M-29.3%222M+34.5%165M+5.7%156M+93.2%80.8M-10.0%89.7M-13.2%
Interest expense19.3M-46.2%35.9M+84.1%19.5M+50.0%13.0M+124.1%5.80M-38.3%9.40M-30.4%
Other non-operating income-28.7M-194.5%-9.75M+25.1%-13.0M+11.0%-14.6M+14.5%-17.1M-1.7%-16.8M-3.9%
Pre-tax income128M-39.6%212M+39.6%152M+7.4%141M+122.2%63.6M-12.7%72.9M-16.3%
Income tax30.7M-30.8%44.4M+29.4%34.3M+31.9%26.0M+28.4%20.3M+408.9%-6.56M-161.7%
Net income97.3M-42.0%168M+42.6%118M+1.9%115M+166.1%43.4M-45.4%79.5M+3.8%
$2.05-38.1%$3.31+44.5%$2.29+2.2%$2.24+166.7%$0.84-45.8%$1.55+4.7%
EPS (basic)$2.06-38.1%$3.33+43.5%$2.32+2.2%$2.27+167.1%$0.85-45.9%$1.57+4.0%
Weighted-avg shares (basic)47.2M-6.3%50.3M-0.7%50.7M-0.2%50.8M-0.5%51.0M+0.7%50.7M-0.0%
Weighted-avg shares (diluted)47.4M-6.7%50.7M-1.3%51.4M-0.0%51.4M+0.1%51.4M+0.1%51.3M-1.0%
Balance Sheetas ofMar 28 ’26as ofMar 29 ’25as ofMar 30 ’24as ofApr 1 ’23as ofApr 2 ’22as ofApr 3 ’21
835M-10.7%935M+21.6%769M-0.1%770M+1.8%756M+9.0%694M+14.9%
Cash & equivalents245M-20.0%307M+71.6%179M-37.1%284M+9.6%259M+34.9%192M+40.1%
Accounts receivable217M+7.0%203M-1.9%207M+15.3%179M+12.4%159M+24.9%128M-22.8%
Inventory306M-16.1%365M+15.1%317M+22.3%259M-11.5%293M-9.2%323M+19.4%
Prepaid expenses66.2M+9.6%60.4M-8.9%66.3M+41.9%46.7M+5.9%44.1M-13.6%51.1M+65.6%
2.40B-2.2%2.45B+11.6%2.20B+13.5%1.93B+4.0%1.86B+2.2%1.82B+43.6%
Property, plant & equipment306M+7.6%284M-8.8%311M+0.2%311M+20.3%258M+18.8%218M-14.1%
Operating lease right-of-use39.6M-16.6%47.5M-14.1%55.3M+3.5%53.4M+1.3%52.7M-11.9%59.9M+14.6%
Goodwill656M+8.6%604M+6.9%565M+21.2%466M-0.2%467M+0.2%466M+121.4%
Intangible assets448M-1.8%456M+12.2%406M+47.3%276M-11.1%310M-15.1%365M+174.6%
Deferred tax assets9.52M+22.0%7.80M+0.8%7.74M+47.7%5.24M+17.3%4.47M-25.6%6.01M+52.9%
Other non-current assets142M-13.6%164M+20.3%136M+27.5%107M+69.3%63.2M-10.8%70.9M+13.6%
283M-51.1%578M+92.5%300M+19.3%252M-43.1%442M+74.5%253M-7.8%
Accounts payable51.1M-23.8%67.0M-8.7%73.4M+14.7%63.9M+9.5%58.4M+16.1%50.3M-0.9%
Deferred revenue42.3M-2.4%43.3M+38.7%31.2M+3.4%30.2M+12.7%26.8M+2.0%26.3M-8.9%
Short-term & current debt5.01M-98.3%304M+2867.6%10.2M-13.2%11.8M-94.5%214M+1158.5%17.0M-77.9%
Current lease liability9.24M+14.0%8.11M-0.3%8.13M+13.6%7.16M-0.5%7.20M-6.6%7.71M+5.5%
Other current liabilities158M+6.9%148M+8.9%136M+21.9%112M-7.9%121M-12.5%139M+41.9%
Long-term debt1.22B+32.4%921M+15.5%798M+5.8%754M+34.8%559M-19.0%691M+126.0%
Non-current lease liability40.9M-18.9%50.5M-12.9%58.0M+3.7%55.9M+0.4%55.7M-11.5%63.0M+21.0%
Operating lease liability (total)50.1M-14.4%58.6M-11.4%66.1M+4.8%63.1M+0.3%62.9M-11.0%70.7M+19.1%
Deferred tax liabilities38.0M-39.2%62.6M-0.1%62.6M+73.1%36.2M+26.0%28.7M-34.5%43.8M+314.9%
Other non-current liabilities59.4M-12.9%68.2M-9.1%75.0M+0.4%74.7M-6.5%79.9M-20.4%100M+12.6%
796M-3.0%821M-14.5%960M+17.4%818M+9.2%749M+2.4%732M+24.6%
Common stock453K-6.0%482K-5.1%508K+0.8%504K-1.4%511K+0.4%509K+1.2%
Additional paid-in capital554M+5.9%523M-17.5%635M+6.7%595M+3.9%572M-5.0%603M+8.9%
Retained earnings279M-20.7%352M-2.3%360M+42.4%253M+25.1%202M+28.1%158M+101.2%
Accumulated other comprehensive income-37.6M+31.7%-55.1M-54.6%-35.6M-17.3%-30.4M-17.1%-26.0M+12.2%-29.5M+34.5%
Total liabilities & equity2.40B-2.2%2.45B+11.6%2.20B+13.5%1.93B+4.0%1.86B+2.2%1.82B+43.6%
Common shares issued45.3M-6.1%48.2M-5.1%50.8M+0.7%50.4M-1.3%51.1M+0.5%50.9M+1.1%
Common shares outstanding45.3M-6.1%48.2M-5.1%50.8M+0.7%50.4M-1.3%51.1M+0.5%50.9M+1.1%
Shares outstanding (cover)45.4M-5.4%48.0M-5.5%50.8M+0.6%50.5M-1.4%51.3M+0.6%51.0M+1.1%
Cash Flowas ofMar 28 ’26as ofMar 29 ’25as ofMar 30 ’24as ofApr 1 ’23as ofApr 2 ’22as ofApr 3 ’21
293M+61.4%182M-0.0%182M-33.4%273M+58.5%172M+58.3%109M-31.2%
Depreciation & amortization112M-3.3%116M+18.9%97.2M+4.2%93.3M-4.5%97.7M+16.0%84.3M-23.6%
Intangible amortization50.5M-9.2%55.6M+34.3%41.4M-1.7%42.1M-25.6%56.6M+37.4%41.2M+20.5%
Share-based compensation33.8M+14.1%29.6M+4.6%28.3M+10.7%25.6M+5.0%24.4M-4.5%25.5M+24.7%
Deferred income taxes-26.4M-369.5%-5.62M+48.3%-10.9M-288.3%5.78M+14.5%5.05M+124.2%-20.8M-209.7%
Change in receivables14.9M+313.9%-6.96M-128.8%24.2M-0.9%24.4M-30.2%35.0M+179.3%-44.1M-133.9%
Change in inventory-47.4M-173.2%64.7M+7.7%60.1M+295.3%-30.8M-26.5%-24.3M-162.5%38.9M-54.1%
Other operating activities10.7M+7.5%9.98M-14.2%11.6M+24.8%9.32M+66.7%5.59M+272.8%1.50M-33.6%
-180M-10.9%-162M+49.8%-322M-124.2%-144M-66.5%-86.3M+79.7%-425M-644.1%
Capital expenditure32.8M-16.5%39.3M+3.0%38.1M-80.1%191M+98.2%96.5M+160.6%37.0M-24.0%
Free cash flow260M+82.8%142M-0.8%144M+75.7%81.7M+7.9%75.8M+5.6%71.8M-34.4%
Acquisitions60.2M-60.1%151M-38.1%244M+8456.2%2.85M+14.0%2.50M-99.4%435M
Proceeds from sale of PP&E1.38M-94.1%23.3M+1184.7%1.81M+12.6%1.61M-20.5%2.02M+11.4%1.81M-89.2%
-178M-264.0%109M+185.2%38.2M+138.0%-100M-537.3%-15.7M-104.3%367M+380.1%
Long-term debt issued0.000.000.000.000.000.00
Long-term debt repaid0.00-100.0%4.69M-61.7%12.3M+27.3%9.63M-45.0%17.5M-20.0%21.9M+66.7%
Net short-term debt———0.000.00+100.0%-60.0M-233.3%
Common stock issued0.000.000.000.000.000.00
Common stock repurchased175M-22.2%225M0.00-100.0%75.0M0.000.00-100.0%
Dividends paid0.000.000.000.000.000.00
Other financing activities-102K+59.0%-249K+73.0%-922K-1995.5%-44.0K-780.0%-5.00K+89.1%-46.0K+53.5%
FX effect on cash3.46M+605.5%-685K+78.5%-3.19M+19.1%-3.94M-32.2%-2.98M-171.3%4.18M+323.1%
Net change in cash-61.3M-147.9%128M+221.1%-106M-523.2%25.0M-62.8%67.2M+22.2%55.0M+271.6%
Interest paid17.5M+5.6%16.5M-20.9%20.9M+53.8%13.6M+119.6%6.19M-20.9%7.82M-37.6%
Income taxes paid60.7M+23.1%49.3M-6.5%52.7M+193.3%18.0M-26.1%24.3M+94.6%12.5M+8.5%
Valuation Ratiosas ofMar 28 ’26as ofMar 29 ’25as ofMar 30 ’24as ofApr 1 ’23as ofApr 2 ’22as ofApr 3 ’21
Market cap2.51B-20.9%3.17B-26.8%4.33B+3.8%4.17B+27.9%3.26B-42.7%5.69B+12.1%
P/E14.3×-41.4%24.4×-28.7%34.2×-21.4%43.6×-69.8%144.4×+174.3%52.7×-17.3%
P/S1.9×-17.6%2.3×-32.3%3.4×-7.7%3.7×+8.0%3.4×-46.9%6.4×+26.8%
P/B2.8×-21.3%3.5×-23.8%4.6×-14.6%5.4×+20.5%4.5×-43.6%7.9×-10.4%
P/FCF8.2×-74.6%32.1×-46.1%59.6×+82.8%32.6×-67.3%99.7×+105.9%48.4×-23.1%
Earnings yield7.0%+70.5%4.1%+40.3%2.9%+27.3%2.3%+231.3%0.69%-63.5%1.9%+20.9%
FCF yield12.3%+293.6%3.1%+85.6%1.7%-45.3%3.1%+206.0%1.0%-51.4%2.1%+30.1%
Source filing10-K10-K10-K10-K10-K10-K

About this data

Source: HAE’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HAE filings on SEC EDGAR → Not investment advice.